Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds

Peter Abadir, Sayed Hosseini, Mahya Faghih, Amir Ansari, Frank Lay, Barbara Smith, Aleksandra Beselman, Diep Vuong, Alan Berger, Jing Tian, David A Rini, Kevin Keenahan, Joshua Budman, Tadashi Inagami, Neal S Fedarko, Guy Marti, John Harmon, Jeremy D Walston

Research output: Contribution to journalArticle

Abstract

Chronic wounds are among the most devastating and difficult to treat consequences of diabetes. Dysregulation of the skin renin-angiotensin system is implicated in abnormal wound healing in diabetic and older adults. Given this, we sought to determine the effects of topical reformulations of the angiotensin type 1 receptor blockers losartan and valsartan and the angiotensin-converting enzyme inhibitor captopril on wound healing in diabetic and aged mice with further validation in older diabetic pigs. The application of 1% valsartan gel compared with other tested formulations and placebo facilitated and significantly accelerated closure time and increased tensile strength in mice, and was validated in the porcine model. One percent of valsartan gel-treated wounds also exhibited higher mitochondrial content, collagen deposition, phosphorylated mothers against decapentaplegic homologs 2 and 3 and common mothers against decapentaplegic homolog 4, alpha-smooth muscle actin, CD31, phospho-vascular endothelial growth factor receptor 2, and p42/44 mitogen-activated protein kinase. Knockout of the angiotensin subtype 2 receptors abolished the beneficial effects of angiotensin type 1 receptor blockers, suggesting a role for angiotensin subtype 2 receptors in chronic wound healing.

Original languageEnglish (US)
Pages (from-to)434-443
Number of pages10
JournalJournal of Investigative Dermatology
Volume138
Issue number2
DOIs
StatePublished - Feb 1 2018

Fingerprint

Valsartan
Angiotensins
Smad Proteins
Wound Healing
Angiotensin II Type 1 Receptor Blockers
Wounds and Injuries
Swine
Gels
Vascular Endothelial Growth Factor Receptor-2
Losartan
Tensile Strength
Mitogen-Activated Protein Kinase 1
Captopril
Renin-Angiotensin System
Medical problems
Mitogen-Activated Protein Kinases
Angiotensin-Converting Enzyme Inhibitors
Renin
Smooth Muscle
Muscle

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds. / Abadir, Peter; Hosseini, Sayed; Faghih, Mahya; Ansari, Amir; Lay, Frank; Smith, Barbara; Beselman, Aleksandra; Vuong, Diep; Berger, Alan; Tian, Jing; Rini, David A; Keenahan, Kevin; Budman, Joshua; Inagami, Tadashi; Fedarko, Neal S; Marti, Guy; Harmon, John; Walston, Jeremy D.

In: Journal of Investigative Dermatology, Vol. 138, No. 2, 01.02.2018, p. 434-443.

Research output: Contribution to journalArticle

Abadir, P, Hosseini, S, Faghih, M, Ansari, A, Lay, F, Smith, B, Beselman, A, Vuong, D, Berger, A, Tian, J, Rini, DA, Keenahan, K, Budman, J, Inagami, T, Fedarko, NS, Marti, G, Harmon, J & Walston, JD 2018, 'Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds', Journal of Investigative Dermatology, vol. 138, no. 2, pp. 434-443. https://doi.org/10.1016/j.jid.2017.09.030
Abadir, Peter ; Hosseini, Sayed ; Faghih, Mahya ; Ansari, Amir ; Lay, Frank ; Smith, Barbara ; Beselman, Aleksandra ; Vuong, Diep ; Berger, Alan ; Tian, Jing ; Rini, David A ; Keenahan, Kevin ; Budman, Joshua ; Inagami, Tadashi ; Fedarko, Neal S ; Marti, Guy ; Harmon, John ; Walston, Jeremy D. / Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds. In: Journal of Investigative Dermatology. 2018 ; Vol. 138, No. 2. pp. 434-443.
@article{3903d9cd820041809e570c1d268f85db,
title = "Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds",
abstract = "Chronic wounds are among the most devastating and difficult to treat consequences of diabetes. Dysregulation of the skin renin-angiotensin system is implicated in abnormal wound healing in diabetic and older adults. Given this, we sought to determine the effects of topical reformulations of the angiotensin type 1 receptor blockers losartan and valsartan and the angiotensin-converting enzyme inhibitor captopril on wound healing in diabetic and aged mice with further validation in older diabetic pigs. The application of 1{\%} valsartan gel compared with other tested formulations and placebo facilitated and significantly accelerated closure time and increased tensile strength in mice, and was validated in the porcine model. One percent of valsartan gel-treated wounds also exhibited higher mitochondrial content, collagen deposition, phosphorylated mothers against decapentaplegic homologs 2 and 3 and common mothers against decapentaplegic homolog 4, alpha-smooth muscle actin, CD31, phospho-vascular endothelial growth factor receptor 2, and p42/44 mitogen-activated protein kinase. Knockout of the angiotensin subtype 2 receptors abolished the beneficial effects of angiotensin type 1 receptor blockers, suggesting a role for angiotensin subtype 2 receptors in chronic wound healing.",
author = "Peter Abadir and Sayed Hosseini and Mahya Faghih and Amir Ansari and Frank Lay and Barbara Smith and Aleksandra Beselman and Diep Vuong and Alan Berger and Jing Tian and Rini, {David A} and Kevin Keenahan and Joshua Budman and Tadashi Inagami and Fedarko, {Neal S} and Guy Marti and John Harmon and Walston, {Jeremy D}",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/j.jid.2017.09.030",
language = "English (US)",
volume = "138",
pages = "434--443",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds

AU - Abadir, Peter

AU - Hosseini, Sayed

AU - Faghih, Mahya

AU - Ansari, Amir

AU - Lay, Frank

AU - Smith, Barbara

AU - Beselman, Aleksandra

AU - Vuong, Diep

AU - Berger, Alan

AU - Tian, Jing

AU - Rini, David A

AU - Keenahan, Kevin

AU - Budman, Joshua

AU - Inagami, Tadashi

AU - Fedarko, Neal S

AU - Marti, Guy

AU - Harmon, John

AU - Walston, Jeremy D

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Chronic wounds are among the most devastating and difficult to treat consequences of diabetes. Dysregulation of the skin renin-angiotensin system is implicated in abnormal wound healing in diabetic and older adults. Given this, we sought to determine the effects of topical reformulations of the angiotensin type 1 receptor blockers losartan and valsartan and the angiotensin-converting enzyme inhibitor captopril on wound healing in diabetic and aged mice with further validation in older diabetic pigs. The application of 1% valsartan gel compared with other tested formulations and placebo facilitated and significantly accelerated closure time and increased tensile strength in mice, and was validated in the porcine model. One percent of valsartan gel-treated wounds also exhibited higher mitochondrial content, collagen deposition, phosphorylated mothers against decapentaplegic homologs 2 and 3 and common mothers against decapentaplegic homolog 4, alpha-smooth muscle actin, CD31, phospho-vascular endothelial growth factor receptor 2, and p42/44 mitogen-activated protein kinase. Knockout of the angiotensin subtype 2 receptors abolished the beneficial effects of angiotensin type 1 receptor blockers, suggesting a role for angiotensin subtype 2 receptors in chronic wound healing.

AB - Chronic wounds are among the most devastating and difficult to treat consequences of diabetes. Dysregulation of the skin renin-angiotensin system is implicated in abnormal wound healing in diabetic and older adults. Given this, we sought to determine the effects of topical reformulations of the angiotensin type 1 receptor blockers losartan and valsartan and the angiotensin-converting enzyme inhibitor captopril on wound healing in diabetic and aged mice with further validation in older diabetic pigs. The application of 1% valsartan gel compared with other tested formulations and placebo facilitated and significantly accelerated closure time and increased tensile strength in mice, and was validated in the porcine model. One percent of valsartan gel-treated wounds also exhibited higher mitochondrial content, collagen deposition, phosphorylated mothers against decapentaplegic homologs 2 and 3 and common mothers against decapentaplegic homolog 4, alpha-smooth muscle actin, CD31, phospho-vascular endothelial growth factor receptor 2, and p42/44 mitogen-activated protein kinase. Knockout of the angiotensin subtype 2 receptors abolished the beneficial effects of angiotensin type 1 receptor blockers, suggesting a role for angiotensin subtype 2 receptors in chronic wound healing.

UR - http://www.scopus.com/inward/record.url?scp=85041693724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041693724&partnerID=8YFLogxK

U2 - 10.1016/j.jid.2017.09.030

DO - 10.1016/j.jid.2017.09.030

M3 - Article

C2 - 29078982

AN - SCOPUS:85041693724

VL - 138

SP - 434

EP - 443

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 2

ER -